ES2360254T3 - Compuestos de ariloxietilamina adecuados para tratamiento de trastornos que respondan a la modulación del receptor de dopamina d3. - Google Patents

Compuestos de ariloxietilamina adecuados para tratamiento de trastornos que respondan a la modulación del receptor de dopamina d3. Download PDF

Info

Publication number
ES2360254T3
ES2360254T3 ES07728098T ES07728098T ES2360254T3 ES 2360254 T3 ES2360254 T3 ES 2360254T3 ES 07728098 T ES07728098 T ES 07728098T ES 07728098 T ES07728098 T ES 07728098T ES 2360254 T3 ES2360254 T3 ES 2360254T3
Authority
ES
Spain
Prior art keywords
phenyl
alkyl
fluorinated
alkoxy
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07728098T
Other languages
English (en)
Spanish (es)
Inventor
Roland Grandel
Wilfried Martin Braje
Andreas Haupt
Sean Colm Turner
Udo Lange
Karla Drescher
Liliane Unger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Abbott GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG filed Critical Abbott GmbH and Co KG
Application granted granted Critical
Publication of ES2360254T3 publication Critical patent/ES2360254T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES07728098T 2006-04-14 2007-04-13 Compuestos de ariloxietilamina adecuados para tratamiento de trastornos que respondan a la modulación del receptor de dopamina d3. Active ES2360254T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06007923 2006-04-14
EP06007923 2006-04-14
US793671P 2006-04-20

Publications (1)

Publication Number Publication Date
ES2360254T3 true ES2360254T3 (es) 2011-06-02

Family

ID=40631425

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07728098T Active ES2360254T3 (es) 2006-04-14 2007-04-13 Compuestos de ariloxietilamina adecuados para tratamiento de trastornos que respondan a la modulación del receptor de dopamina d3.

Country Status (6)

Country Link
CN (1) CN101421243B (zh)
AT (1) ATE496031T1 (zh)
DE (1) DE602007012071D1 (zh)
ES (1) ES2360254T3 (zh)
PE (1) PE20080057A1 (zh)
TW (1) TWI400233B (zh)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW450954B (en) * 1998-05-14 2001-08-21 Pharmacia & Amp Upjohn Company Phenylsulfonamide-phenylethylamines useful as dopamine receptors
AU2003218660A1 (en) * 2002-02-13 2003-09-04 Glaxo Group Limited Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds
GB0411421D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
TWI400233B (zh) 2013-07-01
DE602007012071D1 (de) 2011-03-03
ATE496031T1 (de) 2011-02-15
CN101421243A (zh) 2009-04-29
PE20080057A1 (es) 2008-03-10
TW200808727A (en) 2008-02-16
CN101421243B (zh) 2012-05-30

Similar Documents

Publication Publication Date Title
US7759397B2 (en) 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
US8383641B2 (en) Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
US8486984B2 (en) Aminomethyl substituted bicyclic aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
EP2439203B1 (en) Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
US20120220635A1 (en) Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
ES2360254T3 (es) Compuestos de ariloxietilamina adecuados para tratamiento de trastornos que respondan a la modulación del receptor de dopamina d3.
US7834048B2 (en) Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor